ProQR Therapeutics NV (PRQR)
1.94
-0.02
(-1.02%)
USD |
NASDAQ |
Apr 26, 16:00
1.945
0.00 (0.00%)
After-Hours: 20:00
ProQR Therapeutics Enterprise Value: 31.11M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 31.11M |
| April 25, 2024 | 32.74M |
| April 24, 2024 | 36.81M |
| April 23, 2024 | 37.62M |
| April 22, 2024 | 35.99M |
| April 19, 2024 | 35.18M |
| April 18, 2024 | 24.60M |
| April 17, 2024 | 27.86M |
| April 16, 2024 | 35.99M |
| April 15, 2024 | 39.65M |
| April 12, 2024 | 52.26M |
| April 11, 2024 | 60.40M |
| April 10, 2024 | 57.15M |
| April 09, 2024 | 67.72M |
| April 08, 2024 | 46.57M |
| April 05, 2024 | 53.08M |
| April 04, 2024 | 50.64M |
| April 03, 2024 | 46.16M |
| April 02, 2024 | 44.13M |
| April 01, 2024 | 51.45M |
| March 28, 2024 | 59.58M |
| March 27, 2024 | 66.91M |
| March 26, 2024 | 68.54M |
| March 25, 2024 | 67.72M |
| March 22, 2024 | 66.91M |
| Date | Value |
|---|---|
| March 21, 2024 | 68.54M |
| March 20, 2024 | 74.23M |
| March 19, 2024 | 77.48M |
| March 18, 2024 | 74.23M |
| March 15, 2024 | 81.55M |
| March 14, 2024 | 62.03M |
| March 13, 2024 | 62.84M |
| March 12, 2024 | 40.06M |
| March 11, 2024 | 37.62M |
| March 08, 2024 | 43.32M |
| March 07, 2024 | 32.74M |
| March 06, 2024 | 27.04M |
| March 05, 2024 | 27.86M |
| March 04, 2024 | 31.11M |
| March 01, 2024 | 34.37M |
| February 29, 2024 | 37.21M |
| February 28, 2024 | 35.99M |
| February 27, 2024 | 43.72M |
| February 26, 2024 | 44.13M |
| February 23, 2024 | 39.25M |
| February 22, 2024 | 38.43M |
| February 21, 2024 | 27.86M |
| February 20, 2024 | 27.86M |
| February 16, 2024 | 31.93M |
| February 15, 2024 | 31.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-99.27M
Minimum
Mar 25 2022
448.31M
Maximum
Dec 16 2019
145.44M
Average
156.94M
Median
Enterprise Value Benchmarks
| uniQure NV | -299.44M |
| Merus NV | 2.273B |
| argenx SE | 18.98B |
| Pharming Group | 584.99M |
| Pharvaris NV | 824.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.905M |
| Revenue (Quarterly) | 3.537M |
| Total Expenses (Quarterly) | 13.44M |
| EPS Diluted (Quarterly) | -0.0754 |
| Profit Margin (Quarterly) | -167.0% |
| Earnings Yield | -19.53% |
| Normalized Earnings Yield | -22.23 |